SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-318517
Filing Date
2017-10-25
Accepted
2017-10-25 08:01:03
Documents
9
Period of Report
2017-10-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d480142d8k.htm 8-K 28622
2 EX-4.1 d480142dex41.htm EX-4.1 176389
3 EX-4.2 d480142dex42.htm EX-4.2 76858
4 EX-4.3 d480142dex43.htm EX-4.3 76372
5 EX-10.1 d480142dex101.htm EX-10.1 178017
6 EX-99.1 d480142dex991.htm EX-99.1 6567
7 EX-99.2 d480142dex992.htm EX-99.2 18310
8 GRAPHIC g480142g1025073228457.jpg GRAPHIC 4212
9 GRAPHIC g480142g1025094806688.jpg GRAPHIC 4410
  Complete submission text file 0001193125-17-318517.txt   574553
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 171152092
SIC: 2835 In Vitro & In Vivo Diagnostic Substances